Microbiology of cardiac implantable electronic device infections in Calgary, Canada

Teagan King; Derek S Chew; Jenine Leal; Kristine Cannon; Zuying Zhang; Elissa Rennert-May

doi:10.1017/ash.2024.9

Microbiology of cardiac implantable electronic device infections in Calgary, Canada

Antimicrob Steward Healthc Epidemiol. 2024 Jan 25;4(1):e9. doi: 10.1017/ash.2024.9. eCollection 2024.

Authors

Teagan King¹, Derek S Chew^{1

2

3

4

5}, Jenine Leal^{2

3

6

7}, Kristine Cannon⁷, Zuying Zhang², Elissa Rennert-May^{1

2

3

6

8}

Affiliations

¹ Department of Medicine, University of Calgary, Calgary, AB, Canada.
² Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
³ O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.
⁴ Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.
⁵ Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.
⁶ Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.
⁷ Infection Prevention and Control, Alberta Health Services, Calgary, AB, Canada.
⁸ Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB, Canada.

Abstract

The microbiology of cardiac implantable electronic device (CIED) infections in Calgary, Alberta was described, identifying 50 infections from 2013 to 2019. The majority were Staphylococcus aureus (40.0%). There is significant economic burden, mostly related to inpatient costs, associated with CIED infections. However, there were no significant differences in costs stratified by organism.